,KRASKRAS

Minh T Than1,2, Mark O'Hara1,2, Ben Z Stanger1,2

  • 1Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

PubMed
概括

胰腺癌 (PDAC) 是由KRAS突变驱动的. 用新药向KRAS显示出治疗这种致命疾病和改善患者结果的希望.